Table of Content

1 Immunotherapy Market Overview
1.1 Immunotherapy Product Scope
1.2 Immunotherapy Segment by Type
1.2.1 Global Immunotherapy Sales by Type (2016 & 2021 & 2027)
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Non-Specific Immunotherapy
1.3 Immunotherapy Segment by Application
1.3.1 Global Immunotherapy Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 Immunotherapy Market Estimates and Forecasts (2016-2027)
1.4.1 Global Immunotherapy Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Immunotherapy Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Immunotherapy Price Trends (2016-2027)

2 Immunotherapy Estimates and Forecasts by Region
2.1 Global Immunotherapy Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Immunotherapy Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Immunotherapy Sales Market Share by Region (2016-2021)
2.2.2 Global Immunotherapy Revenue Market Share by Region (2016-2021)
2.3 Global Immunotherapy Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Immunotherapy Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Immunotherapy Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Immunotherapy Estimates and Projections (2016-2027)
2.4.2 Europe Immunotherapy Estimates and Projections (2016-2027)
2.4.3 China Immunotherapy Estimates and Projections (2016-2027)
2.4.4 Japan Immunotherapy Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Immunotherapy Estimates and Projections (2016-2027)
2.4.6 India Immunotherapy Estimates and Projections (2016-2027)

3 Global Immunotherapy Competition Landscape by Players
3.1 Global Top Immunotherapy Players by Sales (2016-2021)
3.2 Global Top Immunotherapy Players by Revenue (2016-2021)
3.3 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunotherapy as of 2020)
3.4 Global Immunotherapy Average Price by Company (2016-2021)
3.5 Manufacturers Immunotherapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Immunotherapy Market Size by Type
4.1 Global Immunotherapy Historic Market Review by Type (2016-2021)
4.1.1 Global Immunotherapy Sales Market Share by Type (2016-2021)
4.1.2 Global Immunotherapy Revenue Market Share by Type (2016-2021)
4.1.3 Global Immunotherapy Price by Type (2016-2021)
4.2 Global Immunotherapy Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Immunotherapy Sales Forecast by Type (2022-2027)
4.2.2 Global Immunotherapy Revenue Forecast by Type (2022-2027)
4.2.3 Global Immunotherapy Price Forecast by Type (2022-2027)

5 Global Immunotherapy Market Size by Application
5.1 Global Immunotherapy Historic Market Review by Application (2016-2021)
5.1.1 Global Immunotherapy Sales Market Share by Application (2016-2021)
5.1.2 Global Immunotherapy Revenue Market Share by Application (2016-2021)
5.1.3 Global Immunotherapy Price by Application (2016-2021)
5.2 Global Immunotherapy Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Immunotherapy Sales Forecast by Application (2022-2027)
5.2.2 Global Immunotherapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Immunotherapy Price Forecast by Application (2022-2027)

6 North America Immunotherapy Market Facts & Figures
6.1 North America Immunotherapy Sales by Company
6.1.1 North America Immunotherapy Sales by Company (2016-2021)
6.1.2 North America Immunotherapy Revenue by Company (2016-2021)
6.2 North America Immunotherapy Sales Breakdown by Type
6.2.1 North America Immunotherapy Sales Breakdown by Type (2016-2021)
6.2.2 North America Immunotherapy Sales Breakdown by Type (2022-2027)
6.3 North America Immunotherapy Sales Breakdown by Application
6.3.1 North America Immunotherapy Sales Breakdown by Application (2016-2021)
6.3.2 North America Immunotherapy Sales Breakdown by Application (2022-2027)

7 Europe Immunotherapy Market Facts & Figures
7.1 Europe Immunotherapy Sales by Company
7.1.1 Europe Immunotherapy Sales by Company (2016-2021)
7.1.2 Europe Immunotherapy Revenue by Company (2016-2021)
7.2 Europe Immunotherapy Sales Breakdown by Type
7.2.1 Europe Immunotherapy Sales Breakdown by Type (2016-2021)
7.2.2 Europe Immunotherapy Sales Breakdown by Type (2022-2027)
7.3 Europe Immunotherapy Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Immunotherapy Market Facts & Figures
8.1 China Immunotherapy Sales by Company
8.1.1 China Immunotherapy Sales by Company (2016-2021)
8.1.2 China Immunotherapy Revenue by Company (2016-2021)
8.2 China Immunotherapy Sales Breakdown by Type
8.2.1 China Immunotherapy Sales Breakdown by Type (2016-2021)
8.2.2 China Immunotherapy Sales Breakdown by Type (2022-2027)
8.3 China Immunotherapy Sales Breakdown by Application
8.3.1 China 152 Sales Breakdown by Application (2016-2021)
8.3.2 China 152 Sales Breakdown by Application (2022-2027)

9 Japan Immunotherapy Market Facts & Figures
9.1 Japan Immunotherapy Sales by Company
9.1.1 Japan Immunotherapy Sales by Company (2016-2021)
9.1.2 Japan Immunotherapy Revenue by Company (2016-2021)
9.2 Japan Immunotherapy Sales Breakdown by Type
9.2.1 Japan Immunotherapy Sales Breakdown by Type (2016-2021)
9.2.2 Japan Immunotherapy Sales Breakdown by Type (2022-2027)
9.3 Japan Immunotherapy Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Immunotherapy Market Facts & Figures
10.1 Southeast Asia Immunotherapy Sales by Company
10.1.1 Southeast Asia Immunotherapy Sales by Company (2016-2021)
10.1.2 Southeast Asia Immunotherapy Revenue by Company (2016-2021)
10.2 Southeast Asia Immunotherapy Sales Breakdown by Type
10.2.1 Southeast Asia Immunotherapy Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Immunotherapy Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Immunotherapy Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Immunotherapy Market Facts & Figures
11.1 India Immunotherapy Sales by Company
11.1.1 India Immunotherapy Sales by Company (2016-2021)
11.1.2 India Immunotherapy Revenue by Company (2016-2021)
11.2 India Immunotherapy Sales Breakdown by Type
11.2.1 India Immunotherapy Sales Breakdown by Type (2016-2021)
11.2.2 India Immunotherapy Sales Breakdown by Type (2022-2027)
11.3 India Immunotherapy Sales Breakdown by Application
11.3.1 India Immunotherapy Sales Breakdown by Application (2016-2021)
11.3.2 India Immunotherapy Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Immunotherapy Business
12.1 Abbvie
12.1.1 Abbvie Corporation Information
12.1.2 Abbvie Business Overview
12.1.3 Abbvie Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abbvie Immunotherapy Products Offered
12.1.5 Abbvie Recent Development
12.2 Amgen, Inc.
12.2.1 Amgen, Inc. Corporation Information
12.2.2 Amgen, Inc. Business Overview
12.2.3 Amgen, Inc. Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen, Inc. Immunotherapy Products Offered
12.2.5 Amgen, Inc. Recent Development
12.3 Biogen
12.3.1 Biogen Corporation Information
12.3.2 Biogen Business Overview
12.3.3 Biogen Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biogen Immunotherapy Products Offered
12.3.5 Biogen Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Business Overview
12.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Immunotherapy Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Celgene
12.5.1 Celgene Corporation Information
12.5.2 Celgene Business Overview
12.5.3 Celgene Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Celgene Immunotherapy Products Offered
12.5.5 Celgene Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Immunotherapy Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Business Overview
12.7.3 Merck Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Immunotherapy Products Offered
12.7.5 Merck Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Business Overview
12.8.3 Novartis Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Immunotherapy Products Offered
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Corporation Information
12.9.2 Pfizer Business Overview
12.9.3 Pfizer Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Immunotherapy Products Offered
12.9.5 Pfizer Recent Development
12.10 Roche
12.10.1 Roche Corporation Information
12.10.2 Roche Business Overview
12.10.3 Roche Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Roche Immunotherapy Products Offered
12.10.5 Roche Recent Development

13 Immunotherapy Manufacturing Cost Analysis
13.1 Immunotherapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immunotherapy
13.4 Immunotherapy Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immunotherapy Distributors List
14.3 Immunotherapy Customers

15 Market Dynamics
15.1 Immunotherapy Market Trends
15.2 Immunotherapy Drivers
15.3 Immunotherapy Market Challenges
15.4 Immunotherapy Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Immunotherapy Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Immunotherapy Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Immunotherapy Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Immunotherapy Sales (K Units) by Region (2016-2021)
Table 5. Global Immunotherapy Sales Market Share by Region (2016-2021)
Table 6. Global Immunotherapy Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Immunotherapy Revenue Share by Region (2016-2021)
Table 8. Global Immunotherapy Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Immunotherapy Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Immunotherapy Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Immunotherapy Revenue Share Forecast by Region (2022-2027)
Table 12. Global Immunotherapy Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Immunotherapy Sales Share by Company (2016-2021)
Table 14. Global Immunotherapy Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Immunotherapy Revenue Share by Company (2016-2021)
Table 16. Global Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapy as of 2020)
Table 17. Global Immunotherapy Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Immunotherapy Manufacturing Sites and Area Served
Table 19. Manufacturers Immunotherapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Immunotherapy Sales (K Units) by Type (2016-2021)
Table 22. Global Immunotherapy Sales Share by Type (2016-2021)
Table 23. Global Immunotherapy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Immunotherapy Price (US$/Unit) by Type (2016-2021)
Table 25. Global Immunotherapy Sales Share by Type (2022-2027)
Table 26. Global Immunotherapy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Immunotherapy Revenue Share by Type (2022-2027)
Table 28. Global Immunotherapy Price (US$/Unit) by Type (2022-2027)
Table 29. Global Immunotherapy Sales (K Units) by Application (2016-2021)
Table 30. Global Immunotherapy Sales Share by Application (2016-2021)
Table 31. Global Immunotherapy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Immunotherapy Price (US$/Unit) by Application (2016-2021)
Table 33. Global Immunotherapy Sales (K Units) by Application (2022-2027)
Table 34. Global Immunotherapy Sales Share by Application (2022-2027)
Table 35. Global Immunotherapy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Immunotherapy Revenue Share by Application (2022-2027)
Table 37. Global Immunotherapy Price (US$/Unit) by Application (2022-2027)
Table 38. North America Immunotherapy Sales (K Units) by Company (2016-2021)
Table 39. North America Immunotherapy Sales Market Share by Company (2016-2021)
Table 40. North America Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Immunotherapy Revenue Market Share by Company (2016-2021)
Table 42. North America Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 43. North America Immunotherapy Sales Market Share by Type (2016-2021)
Table 44. North America Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 45. North America Immunotherapy Sales Market Share by Type (2022-2027)
Table 46. North America Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 47. North America Immunotherapy Sales Market Share by Application (2016-2021)
Table 48. North America Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 49. North America Immunotherapy Sales Market Share by Application (2022-2027)
Table 50. Europe Immunotherapy Sales (K Units) by Company (2016-2021)
Table 51. Europe Immunotherapy Sales Market Share by Company (2016-2021)
Table 52. Europe Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Immunotherapy Revenue Market Share by Company (2016-2021)
Table 54. Europe Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 55. Europe Immunotherapy Sales Market Share by Type (2016-2021)
Table 56. Europe Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 57. Europe Immunotherapy Sales Market Share by Type (2022-2027)
Table 58. Europe Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 59. Europe Immunotherapy Sales Market Share by Application (2016-2021)
Table 60. Europe Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 61. Europe Immunotherapy Sales Market Share by Application (2022-2027)
Table 62. China Immunotherapy Sales (K Units) by Company (2016-2021)
Table 63. China Immunotherapy Sales Market Share by Company (2016-2021)
Table 64. China Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Immunotherapy Revenue Market Share by Company (2016-2021)
Table 66. China Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 67. China Immunotherapy Sales Market Share by Type (2016-2021)
Table 68. China Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 69. China Immunotherapy Sales Market Share by Type (2022-2027)
Table 70. China Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 71. China Immunotherapy Sales Market Share by Application (2016-2021)
Table 72. China Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 73. China Immunotherapy Sales Market Share by Application (2022-2027)
Table 74. Japan Immunotherapy Sales (K Units) by Company (2016-2021)
Table 75. Japan Immunotherapy Sales Market Share by Company (2016-2021)
Table 76. Japan Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Immunotherapy Revenue Market Share by Company (2016-2021)
Table 78. Japan Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 79. Japan Immunotherapy Sales Market Share by Type (2016-2021)
Table 80. Japan Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 81. Japan Immunotherapy Sales Market Share by Type (2022-2027)
Table 82. Japan Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 83. Japan Immunotherapy Sales Market Share by Application (2016-2021)
Table 84. Japan Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 85. Japan Immunotherapy Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Immunotherapy Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Immunotherapy Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Immunotherapy Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Immunotherapy Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Immunotherapy Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Immunotherapy Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Immunotherapy Sales Market Share by Application (2022-2027)
Table 98. India Immunotherapy Sales (K Units) by Company (2016-2021)
Table 99. India Immunotherapy Sales Market Share by Company (2016-2021)
Table 100. India Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Immunotherapy Revenue Market Share by Company (2016-2021)
Table 102. India Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 103. India Immunotherapy Sales Market Share by Type (2016-2021)
Table 104. India Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 105. India Immunotherapy Sales Market Share by Type (2022-2027)
Table 106. India Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 107. India Immunotherapy Sales Market Share by Application (2016-2021)
Table 108. India Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 109. India Immunotherapy Sales Market Share by Application (2022-2027)
Table 110. Abbvie Corporation Information
Table 111. Abbvie Description and Business Overview
Table 112. Abbvie Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Abbvie Immunotherapy Product
Table 114. Abbvie Recent Development
Table 115. Amgen, Inc. Corporation Information
Table 116. Amgen, Inc. Description and Business Overview
Table 117. Amgen, Inc. Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Amgen, Inc. Immunotherapy Product
Table 119. Amgen, Inc. Recent Development
Table 120. Biogen Corporation Information
Table 121. Biogen Description and Business Overview
Table 122. Biogen Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Biogen Immunotherapy Product
Table 124. Biogen Recent Development
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Bristol-Myers Squibb Immunotherapy Product
Table 129. Bristol-Myers Squibb Recent Development
Table 130. Celgene Corporation Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Celgene Immunotherapy Product
Table 134. Celgene Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Johnson & Johnson Immunotherapy Product
Table 139. Johnson & Johnson Recent Development
Table 140. Merck Corporation Information
Table 141. Merck Description and Business Overview
Table 142. Merck Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Merck Immunotherapy Product
Table 144. Merck Recent Development
Table 145. Novartis Corporation Information
Table 146. Novartis Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Novartis Description and Business Overview
Table 148. Novartis Immunotherapy Product
Table 149. Novartis Recent Development
Table 150. Pfizer Corporation Information
Table 151. Pfizer Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Pfizer Description and Business Overview
Table 153. Pfizer Immunotherapy Product
Table 154. Pfizer Recent Development
Table 155. Roche Corporation Information
Table 156. Roche Description and Business Overview
Table 157. Roche Immunotherapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Roche Immunotherapy Product
Table 159. Roche Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Immunotherapy Distributors List
Table 163. Immunotherapy Customers List
Table 164. Immunotherapy Market Trends
Table 165. Immunotherapy Market Drivers
Table 166. Immunotherapy Market Challenges
Table 167. Immunotherapy Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunotherapy Product Picture
Figure 2. Global Immunotherapy Sales Market Share by Type in 2021 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Therapeutic Vaccines Product Picture
Figure 5. Checkpoint Inhibitors Product Picture
Figure 6. Non-Specific Immunotherapy Product Picture
Figure 7. Global Immunotherapy Sales Market Share by Application in 2021 & 2027
Figure 8. Oncology Examples
Figure 9. Inflammation Examples
Figure 10. Central Nervous System Examples
Figure 11. Others Examples
Figure 12. Global Immunotherapy Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Immunotherapy Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Immunotherapy Sales (K Units) Growth Rate (2016-2027)
Figure 15. Global Immunotherapy Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 16. Global Immunotherapy Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Immunotherapy Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Immunotherapy Sales (K Units) Growth Rate (2016-2027)
Figure 20. Europe Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Immunotherapy Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Immunotherapy Players Market Share by Revenue in Immunotherapy: 2016 & 2020
Figure 31. Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Immunotherapy Revenue Share by Type (2016-2021)
Figure 33. Global Immunotherapy Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Immunotherapy Revenue Share by Application (2016-2021)
Figure 35. Global Immunotherapy Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Immunotherapy Sales Market Share by Type in 2020
Figure 37. North America Immunotherapy Sales Market Share by Application in 2020
Figure 38. Europe Immunotherapy Sales Market Share by Type in 2020
Figure 39. Europe Immunotherapy Sales Market Share by Application in 2020
Figure 40. China Immunotherapy Sales Market Share by Type in 2020
Figure 41. China Immunotherapy Sales Market Share by Application in 2020
Figure 42. Japan Immunotherapy Sales Market Share by Type in 2020
Figure 43. Japan Immunotherapy Sales Market Share by Application in 2020
Figure 44. Southeast Asia Immunotherapy Sales Market Share by Type in 2020
Figure 45. Southeast Asia Immunotherapy Sales Market Share by Application in 2020
Figure 46. India Immunotherapy Sales Market Share by Type in 2020
Figure 47. India Immunotherapy Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Immunotherapy
Figure 50. Manufacturing Process Analysis of Immunotherapy
Figure 51. Immunotherapy Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed